Follow The Filings

VREX Varex Imaging Corporation

Information Technology, filed as VAREX IMAGING CORP (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Bought by 2 managers in 2026 Q2

  • 2 Owners
  • Max 0.1%
  • $47M
  • 1 new 1 add

In 2026 Q2 First Eagle Investment Management opened a position in Varex Imaging, and Richard Pzena added.

Who owns this now

Largest portfolio weights among holders, up to 0.1% (Richard Pzena, Pzena Investment Management). Not free-float ownership.

  1. Richard Pzena Add 0.13%

Who owns VREX

Sorted by value, long equity only, as of 2026 Q2.

History
Richard Pzena, Pzena Investment Management 0.13% Add +8.8% 4,344,381 $45M History
First Eagle Investment Management <0.01% New <0.01% 179,501 $1.9M History

2 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by VREX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All VREX insider trades
  • None no insider bought on the open market
  • $200K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Jay K. Kunkel Director
    Sale
    $150K 8,121 shares at $18.48 35% of stake
    Traded Sep 14 Filed Sep 15
    ↗
  2. Jay K. Kunkel Director
    Sale
    $50K 4,510 shares at $11.14 16% of stake
    Traded Mar 20 Filed Mar 23
    ↗

Also filed in the last 12 months, not counted as buying or selling: 17 option exercises, 6 share withholdings for taxes, and 1 sale to cover taxes.

SEC filings

Recent issuer filings from EDGAR, 22 shown.

Filed Form Detail Links
DEFA14A Filing Doc
8-K 8.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
DEFA14A DEFA14A - VAREX CUSTOMER TALKING POINTS FAQ Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.01,5.02,7.01,9.01 Filing Doc
DEFA14A Filing Doc
10-Q Filing Doc
DEFA14A DEFA14A - LETTER TO SUPPLIERS Filing Doc
DEFA14A DEFA14A - LETTER TO CUSTOMERS Filing Doc
DEFA14A DEFA14A - ANNOUNCEMENTS TO EMPLOYEES Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 1.01,1.02,2.03,8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A FORM DEF 14A Filing Doc
DEFA14A Filing Doc

Source: SEC EDGAR submissions, updated 1 day ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $893.4M $811M $844.6M
Gross profit $290.3M $256.9M $290.5M
Gross margin * 32.5% 31.7% 34.4%
Net income $48.2M -$47.7M -$70.3M
Net margin * 5.4% -5.9% -8.3%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $658.3M $649.9M $641.8M
Total non-current assets * $591.3M $567.1M $465.6M
Total assets $1.25B $1.22B $1.11B
Total current liabilities $162.8M $195.9M $187.2M
Total non-current liabilities * $505.8M $471.9M $433.6M
Total equity $567.7M $535.1M $472.6M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $108.4M $47.3M $41.7M
Cash from investing -$44.9M -$27.5M $10.3M
Cash from financing -$0.2M -$3.3M -$75.9M
Net change in cash $63.4M $16.4M -$23.3M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.